Annwall & Rothschild Investments AB (A & R AB) has due to private financial
reasons sold 500,000 B-shares in BioGaia AB to a few long term investors. After
the sale A & R AB owns 8.7 % of the capital and 34.1 % of the votes. A & R AB
has no intention to sell additional shares in BioGaia in the foreseeable future.
BioGaia has published this information in accordance with the Swedish Securities
Market Act. The information was issued for publication on 26 March 2014, 08:45
am CET.
For additional information please contact
Peter Rothschild, President, BioGaia: +46 8 555 293 00
BioGaia is a healthcare company that develops, markets and sells probiotic
products with documented health benefits. The products are primarily based on
the lactic acid bacterium Lactobacillus reuteri, which has probiotic, health
-enhancing effects. The class B share of the Parent Company BioGaia AB is quoted
on the Mid Cap list of the NASDAQ OMX Nordic Exchange Stockholm. www.biogaia.com
